By: IPP Bureau
Last updated : May 03, 2025 1:34 pm
The FDA issued Form 483 with one observation related to building and facility management
The United States Food and Drug Administration (USFDA) has inspected Neuland Laboratories Limited's Unit 2 manufacturing facility, located at Pashamylaram village, Sangareddy District, from April 28, 2025 to May 2, 2025.
The FDA issued Form 483, with one observation related to building and facility management, which the company will respond to within the stipulated timelines.